发明授权
US08362212B2 Engineered anti-IL-23 antibodies 有权
工程抗IL-23抗体

Engineered anti-IL-23 antibodies
摘要:
Engineered antibodies to human IL-23p19 are provided, as well as uses thereof, e.g. in treatment of inflammatory, autoimmune, and proliferative disorders.
公开/授权文献
信息查询
0/0